These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23961833)

  • 21. Cost-effectiveness of electronic- and clinician-delivered screening, brief intervention and referral to treatment for women in reproductive health centers.
    Olmstead TA; Yonkers KA; Ondersma SJ; Forray A; Gilstad-Hayden K; Martino S
    Addiction; 2019 Sep; 114(9):1659-1669. PubMed ID: 31111591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness and cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs: a systematic review and economic evaluation.
    Hayhurst KP; Leitner M; Davies L; Flentje R; Millar T; Jones A; King C; Donmall M; Farrell M; Fazel S; Harris R; Hickman M; Lennox C; Mayet S; Senior J; Shaw J
    Health Technol Assess; 2015 Jan; 19(6):1-168, vii-viii. PubMed ID: 25619533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.
    Goldstein LH; Robinson EJ; Pilecka I; Perdue I; Mosweu I; Read J; Jordan H; Wilkinson M; Rawlings G; Feehan SJ; Callaghan H; Day E; Purnell J; Baldellou Lopez M; Brockington A; Burness C; Poole NA; Eastwood C; Moore M; Mellers JD; Stone J; Carson A; Medford N; Reuber M; McCrone P; Murray J; Richardson MP; Landau S; Chalder T
    Health Technol Assess; 2021 Jun; 25(43):1-144. PubMed ID: 34196269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial.
    Murphy SM; Campbell AN; Ghitza UE; Kyle TL; Bailey GL; Nunes EV; Polsky D
    Drug Alcohol Depend; 2016 Apr; 161():119-26. PubMed ID: 26880594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost and cost-effectiveness of an enhanced intervention for people with substance abuse problems at risk for HIV.
    Zarkin GA; Lindrooth RC; Demiralp B; Wechsberg W
    Health Serv Res; 2001 Jun; 36(2):335-55. PubMed ID: 11409816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders.
    Clark RE; Teague GB; Ricketts SK; Bush PW; Xie H; McGuire TG; Drake RE; McHugo GJ; Keller AM; Zubkoff M
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1285-308. PubMed ID: 9865221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using smartphones to decrease substance use via self-monitoring and recovery support: study protocol for a randomized control trial.
    Scott CK; Dennis ML; Gustafson DH
    Trials; 2017 Aug; 18(1):374. PubMed ID: 28797307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cost-effectiveness of brief intervention versus brief treatment of Screening, Brief Intervention and Referral to Treatment (SBIRT) in the United States.
    Barbosa C; Cowell A; Dowd W; Landwehr J; Aldridge A; Bray J
    Addiction; 2017 Feb; 112 Suppl 2():73-81. PubMed ID: 28074567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.
    Mojtabai R; Zivin JG
    Health Serv Res; 2003 Feb; 38(1 Pt 1):233-59. PubMed ID: 12650390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT.
    Bruce J; Mazuquin B; Mistry P; Rees S; Canaway A; Hossain A; Williamson E; Padfield EJ; Lall R; Richmond H; Chowdhury L; Lait C; Petrou S; Booth K; Lamb SE; Vidya R; Thompson AM
    Health Technol Assess; 2022 Feb; 26(15):1-124. PubMed ID: 35220995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs.
    Schackman BR; Leff JA; Barter DM; DiLorenzo MA; Feaster DJ; Metsch LR; Freedberg KA; Linas BP
    Addiction; 2015 Jan; 110(1):129-43. PubMed ID: 25291977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilizing Recovery Management Checkups to shorten the cycle of relapse, treatment reentry, and recovery.
    Scott CK; Dennis ML; Foss MA
    Drug Alcohol Depend; 2005 Jun; 78(3):325-38. PubMed ID: 15893164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial.
    Richards DA; Bower P; Chew-Graham C; Gask L; Lovell K; Cape J; Pilling S; Araya R; Kessler D; Barkham M; Bland JM; Gilbody S; Green C; Lewis G; Manning C; Kontopantelis E; Hill JJ; Hughes-Morley A; Russell A
    Health Technol Assess; 2016 Feb; 20(14):1-192. PubMed ID: 26910256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.
    Murphy SM; Polsky D; Lee JD; Friedmann PD; Kinlock TW; Nunes EV; Bonnie RJ; Gordon M; Chen DT; Boney TY; O'Brien CP
    Addiction; 2017 Aug; 112(8):1440-1450. PubMed ID: 28239984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatments compared with early structured physiotherapy in secondary care for adults with primary frozen shoulder: the UK FROST three-arm RCT.
    Brealey S; Northgraves M; Kottam L; Keding A; Corbacho B; Goodchild L; Srikesavan C; Rex S; Charalambous CP; Hanchard N; Armstrong A; Brooksbank A; Carr A; Cooper C; Dias J; Donnelly I; Hewitt C; Lamb SE; McDaid C; Richardson G; Rodgers S; Sharp E; Spencer S; Torgerson D; Toye F; Rangan A
    Health Technol Assess; 2020 Dec; 24(71):1-162. PubMed ID: 33292924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Net Benefits of Recovery High Schools: Higher Cost but Increased Sobriety and Educational Attainment.
    Weimer DL; Moberg P; French F; Tanner-Smith EE; Finch AJ
    J Ment Health Policy Econ; 2019 Sep; 22(3):109-120. PubMed ID: 31811754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pay-for-performance as a cost-effective implementation strategy: results from a cluster randomized trial.
    Garner BR; Lwin AK; Strickler GK; Hunter BD; Shepard DS
    Implement Sci; 2018 Jul; 13(1):92. PubMed ID: 29973280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.